RoncoC., ParenzanL.. Acute renal failure in infancy: treatment by continuous renal replacement therapy. Intensive Care Med1995; 21: 490–9.
2.
BelshaC.W., KohautE.C., WaradyB.A.. Dialytic management of childhood acute renal failure: a survey of North American pediatric nephrologists. Pediatr Nephrol1995; 9: 361–3.
3.
GouyonJ.B., CochatP., HouzelC., SemamaD., StammD.. Sur-vey on the practice of extrarenal hemofiltration in pediatrics. Arch Pediatr1996; 3: 769–74.
4.
RoncoC., BellomoR.. Basic mechanisms and definitions for continuous renal replacement therapies. Int J Artif Organs1996; 19: 95–9.
5.
ForniL.G., HiltonP.J.. Continous hemofiltration in the treatment of acute renal failure. N Eng J Med1997; 336: 1303–8.
6.
BellomoR., RoncoC., MehtaR.L.. Nomenclature for continuous renal replacement therapies. Am J Kidney Dis1996; 28(suppl. 3): S2–7.
7.
ZobelG., RingE., RodiS.. Continuous renal replacement therapy in critically ill pediatric patients. Am J Kidney Dis1996; 28(suppl. 3): S28–34.
8.
RoncoC.. Continuous renal replacement therapies in the treatment of acute renal failure in intensive care patients. Nephrol Dial Transplant1994; 9(suppl. 4): S191–200.
9.
SiegelN.J., Van WhyS.K., BoydstunI.I.Acute renal failure. Clinical aspects. In: HollidayM.A., BarratT.M., AvnerE.D., eds. Pediatric nephrology.Baltimore: William & Wilkins, 1994; 1186–203.
10.
ZobelG., TropM., BeitzkeA., RingE.. Vascular access for continuous arteriovenous hemofiltration in infants and young children. Int J Artif Organs1988; 12: 16–9.
11.
MehtaR.L.. Anticoagulation strategies for continuous renal replacement therapies: What works?Am J Kidney Dis1996; 28(suppl. 3): S8–14.
GretzN., QuintelM., RagallerM.Low dose heparinization for anticoagulation in intensive care patients on continuous hemofiltration. In: SieberthH.G., StunmvollH.K., KierdofH., eds. Continuous extracorporeal treatment in multiple organ dysfunction syndrome.Basel: Karger, 1995; 130–5.
14.
BastienO., FrenchP., PaulusS.Anthithrombin III deficiency during continuous venovenous hemodialysis. In: SieberthH.G., StunmvollH.K., KierdofH., eds. Continuous extracorporeal treatment in multiple organ dysfunction syndrome.Basel: Karger, 1995; 154–8.
15.
BellomoR., TeedeH., BoyceN.. Anticoagulant regimens in acute continuous hemodiafiltration. A comparative study. Int Care Med1993; 19: 329–32.
16.
ZobelG., TropM., MuntanW., RingE., GleispachH.. Anticoagulation for continuous arteriovenous hemofiltration in children. Blood Purif1988; 6: 90–5.
RoncoC.. Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients. Clin Nephrol1993; 40: 187–98.
20.
RoncoC.. Continuous renal replacement therapies in the treatment of acute renal failure in intensive care patients. Clinical indications and prescription. Nephrol Dial Transplant1994; 9(suppl. 4): S201–9.
21.
KramerP., BuhlerJ., KehrA.Intensive care potential of continuous arteriovenous hemodialysis. Trans ASAIO1982; 28: 28–32.
22.
LittleR.A., CampbellI.T., GreenC.J., KishenR., WaldekS.. Nutritional support in acute renal failure in the critically ill. In: BihariD., NeilG., eds. Acute renal failure in the Intensive Therapy Unit.Heidelberg: Springer Verlag, 1990; 347–56.
23.
BoschJ.P., RoncoC.. Continous arteriovenous hemofiltration. In: MaherJ.F., ed. Rcplacement of renal function by dialysis.Dordrecht: Kluwer Academic Publ, 1989; 15: 347–61.
24.
ZobelG., RingE., TropM., SteinJ.I.. Arteriovenous hemodiafiltration in children. Int J Pediatr Nephrol1986; 7: 203–6.
25.
BunchmanT.E., MaxvoldN.J., KershawD.B.. Continuous venovenous hemodiafiltration in infants and children. Am J Kidney Dis1995; 25: 17–21.
BellomoR., RoncoC.. The nutritional management of acute renal failure in the critically ill patient. Am J Kidney Dis1996; 28(suppl. 3): S58–61.
28.
JaberB.L., PereiraB.J.G.. Inflammatory mediators in sepsis: Rationale for extracorporeal therapies ?Am J Kidney Dis1996; 28(suppl. 3): S35–49.
29.
RoncoC., TettaC., LupiA.Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med1995; 23: 99–107.
30.
BellomoR., TippingP., BoyceN.. Continuous veno venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med1993; 21: 522–6.
31.
WendonJ.A., HarrisonP.M., KeaysR., GimsonA.E.S., AlexanderG.J.M., WilliamsR.. Effects of vasopressor agents and epoprostenol on systemic hemodynamic and oxygen transport in fulminant hepatic failure. Hepatology1992; 15: 1067–71.
32.
DavenportA.. Continuous renal replacement therapy in patients with hepatic and acute renal failure. Am J Kidney Dis1996; 28(suppl.): S62–6.
33.
DavenportA., WllE.J., DavisonA.M.. Membrane biocompatibility: Effects on cardiovascular stability in patients on hemofiltration. Kidney Int1993; 43(suppl.): S230–4.
34.
ThompsonG.N., ButtW.W., ShannF.A.Continuous veno-venous hemofiltration in the management of acute decompensation in inborn errors of metabolism. J Pediatr1991; 118: 879–84.
35.
FalkM., KnightJ.F., RoyL.P.Continuous venovenous hemofiltration in the acute treatment of inborn errors of metabolism. Pediatr Nephrol1994; 8: 330–3.
36.
SaccenteS., KohautE.C., BerkowR.L.. Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration. Pediatr Nephrol1995; 9: 569–73.
37.
HeneyD., Essex-CaterA., BrocklebankJ.T., BaileyC.C., LewisI.J.. Continuous arteriovenous hemofiltration in the treatment of tumor lysis syndrome. Pediatr Nephrol1990; 4: 245–7.
38.
LauerA., SacaggiA., RoncoC., BelledonneM., GlabmanS., BoschJ.P.. Continuous arteriovenous hemofiltration in the critically ill patient. Ann Intern Med1983; 99: 455–60.
39.
RoncoC., BellomoR.. Complications with continuous renal replacement therapy. Am J Kidney Dis1996; 28(suppl. 3): S100–4.
40.
ClarkW.R., MuellerB.A., AlakaK.J., MaciasW.L.. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol1994; 4: 1413–20.
41.
DavenportA., RobertsN.B.. Aminoacid losses during continuous high-flux hemofiltration in the critically ill patient. Crit Care Med1989; 17: 1010–4.
42.
FryD.E., PearlsteinL., FultonR.L., PohlH.C.Jr.. Multiple systemic organ failure. The role of uncontrolled infection. Arch Surg1980; I 15: 136–41.
43.
ManshipL., McMillinR.D., BrownL.L.. The influence of sepsis and multisystemic organ failure on mortality in the surgical intensive care unit. Am Surg1984; 50: 94–100.
44.
SmoyerW.E., McAdamsC., KaplanB.S., SherbotieJ.R.. Determinants of survival in pediatric continuous hemofiltration. J Am Soc Nephrol1995; 6: 1401–9.
45.
KierdofH.. Continuous versus intermittent treatment: clinical results in acute renal failure. Contrib Nephrol1991; 93: 1–12.
46.
McDonaldB.R., MehtaR.L.. Decreased mortality in patients with acute renal failure undergoing continuous arteriovenous hemodialysis. Contrib Nephrol1991; 93: 51–6.
47.
KelleherS.P., RobinetteJ.B., MillerF., CongerJ.D.. Effect of hemorragic reduction in blood pressure on recovery from acute renal failure. Kidney Int1987; 31: 725–30.
48.
HakimR.M., WingardR.L., ParkerR.A.. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med1994; 331: 1338–42.
49.
RahmanS.N., ButtA.R., DuBoseT.D.Differential clinical effects of anaritide atrial natriuretic peptide (ANP) in oliguric and non-oliguric ATN (Abstract). J Am Soc Nephrol1995; 6: 474A.
50.
CongerJ.D.. The role of continuous renal replacement therapy in the future treatment of acute renal failure. Am J Kidney Dis1996; 28(suppl.): S108–13.